Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625431 | PMC |
http://dx.doi.org/10.2147/JPR.S506274 | DOI Listing |
J Formos Med Assoc
December 2024
Stroke Center and Department of Neurology, National Taiwan University Hospital, Taiwan.
J Pain Res
December 2024
Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
World J Hepatol
November 2024
Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Rome 00185, Italy.
Hepatic encephalopathy (HE) is one of the main complications of cirrhosis, characterized by a wide spectrum of neuropsychiatric alterations that lead to an increase in mortality, morbidity and recurrent hospitalizations. Due to the central role in HE pathogenesis of ammonia and other neurotoxins primarily produced by the gut microbiota, the main therapeutic approaches for the treatment of HE are based on the modulation of the gut microbiota. Rifaximin is a non-absorbable broad-spectrum antibiotic, that is effective against ammonia-producing gram-positive, gram-negative, and anaerobic species, approved for the treatment of HE in secondary prophylaxis.
View Article and Find Full Text PDFJ Pain Res
November 2024
Tianjin University of Traditional Chinese Medical, Tianjin, People's Republic of China.
N Engl J Med
November 2024
San Carlo Hospital, Potenza, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!